Laparoscopic versus robot-assisted radical prostatectomy using the hood technique: oncological and functional outcomes in a retrospective cohort

Objective To assess the feasibility of conventional laparoscopic implementation of the Hood technique through comparison with robot-assisted surgery, with inpatient expenditure as a secondary outcome. Methods This single-center retrospective cohort included 91 patients treated between March 2024 and September 2025: 44 underwent laparoscopic radical prostatectomy using the Hood technique (LRP-Hood) and 47 underwent robot-assisted surgery using the same technique (RARP-Hood). Each platform was operated by a designated surgeon. Unadjusted outcomes and recorded inpatient costs were compared; absolute differences were expressed as LRP-Hood minus RARP-Hood. Results Positive surgical margin rates were 11.4% versus 8.5% (difference, +2.9 percentage points; 95% confidence interval [CI], −10.2 to 16.5), and biochemical recurrence proportions were 6.8% versus 8.5%. Continence rates were numerically lower after LRP-Hood at 1 week (38.6% vs 48.9%; difference, −10.3 percentage points; 95% CI, −29.2 to 9.8) and were 97.7% versus 100.0% at 12 months after catheter removal ( P = 0.484). No statistically significant differences were detected in these outcomes. At 12 months, 70.5% versus 70.2% attained a five-item International Index of Erectile Function (IIEF-5) score ≥17 ( P = 1.000), with phosphodiesterase type 5 inhibitors permitted; baseline IIEF-5 scores were unavailable in the analysis dataset. Operative time was shorter after LRP-Hood (153.1 ± 30.4 vs. 170.0 ± 28.8 min; P = 0.008), but estimated blood loss was greater (184.5 vs. 132.0 mL; P = 0.002). Inpatient costs were 29,106.8 ± 2,548.8 versus 51,927.4 ± 4,014.8 Chinese yuan ( P < 0.001). Conclusion These findings support laparoscopic Hood surgery as technically feasible in experienced hands. Clinically important outcome differences remain possible, and surgeon and platform effects cannot be separated. Lower inpatient expenditure is a secondary finding; neither clinical equivalence nor cost-effectiveness is established.

Authors

Institutions

Publication Details

Journal
Frontiers in Surgery
Published
2026-11-16
DOI
https://doi.org/10.3389/fsurg.2026.2016310
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Laparoscopic versus robot-assisted radical prostatectomy using the hood technique: oncological and functional outcomes in a retrospective cohort

HUIXING PAN, Jiangnan Xu
3 links
Frontiers in Surgery
Prostate Cancer Diagnosis and Treatment
article

Laparoscopic versus robot-assisted radical prostatectomy using the hood technique: oncological and functional outcomes in a retrospective cohort

HUIXING PAN, Jiangnan Xu
article en

Abstract

Objective To assess the feasibility of conventional laparoscopic implementation of the Hood technique through comparison with robot-assisted surgery, with inpatient expenditure as a secondary outcome. Methods This single-center retrospective cohort included 91 patients treated between March 2024 and September 2025: 44 underwent laparoscopic radical prostatectomy using the Hood technique (LRP-Hood) and 47 underwent robot-assisted surgery using the same technique (RARP-Hood). Each platform was operated by a designated surgeon. Unadjusted outcomes and recorded inpatient costs were compared; absolute differences were expressed as LRP-Hood minus RARP-Hood. Results Positive surgical margin rates were 11.4% versus 8.5% (difference, +2.9 percentage points; 95% confidence interval [CI], −10.2 to 16.5), and biochemical recurrence proportions were 6.8% versus 8.5%. Continence rates were numerically lower after LRP-Hood at 1 week (38.6% vs 48.9%; difference, −10.3 percentage points; 95% CI, −29.2 to 9.8) and were 97.7% versus 100.0% at 12 months after catheter removal ( P = 0.484). No statistically significant differences were detected in these outcomes. At 12 months, 70.5% versus 70.2% attained a five-item International Index of Erectile Function (IIEF-5) score ≥17 ( P = 1.000), with phosphodiesterase type 5 inhibitors permitted; baseline IIEF-5 scores were unavailable in the analysis dataset. Operative time was shorter after LRP-Hood (153.1 ± 30.4 vs. 170.0 ± 28.8 min; P = 0.008), but estimated blood loss was greater (184.5 vs. 132.0 mL; P = 0.002). Inpatient costs were 29,106.8 ± 2,548.8 versus 51,927.4 ± 4,014.8 Chinese yuan ( P < 0.001). Conclusion These findings support laparoscopic Hood surgery as technically feasible in experienced hands. Clinically important outcome differences remain possible, and surgeon and platform effects cannot be separated. Lower inpatient expenditure is a secondary finding; neither clinical equivalence nor cost-effectiveness is established.

Frontiers in SurgeryVol. 13
Yancheng First People's Hospital (CN), Nanjing University (CN)
Good health and well-being
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon